A biomimetic nanocomposite with enzyme-like activities and CXCR4 antagonism efficiently enhances the therapeutic efficacy of acute myeloid leukemia

Despite the progress made to improve therapeutic outcomes for acute myeloid leukemia AGELESS TELOMERES (AML), many unmet clinical needs remain to be resolved.Unlike existing anti-AML strategies, here we developed a biomimetic nanocomposite to efficiently eliminate the leukemia cells in the bone marrow and prevent the homing of AML.To fulfill our de

read more


Externally triggered drug delivery systems

Externally triggered drug delivery systems empower patients 152 or healthcare providers to utilize external stimuli to initiate drug release from implanted systems.This approach holds significant potential for clinical disease management, offering appealing features like enhanced patient adherence through the elimination of needles and medication r

read more